Tadalafil Tablet, Film Coated
Product Images NDC 68788-8153

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68788-8153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tadalafil Figure1)

This is a table showing the difference in blood pressure (in mmHg) between Tadalafil and Placebo for Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP and Supine Diastolic BP at different time intervals (in hours).*

FDA Label Image

Figure (Tadalafil Figure2)

This appears to be a table showing different variables and values for a study that involves Tadalafil 20 mg & doxazosin 8 mg, as well as Placebo & doxazosin 8 mg. The first row shows the values "10", "3", and "5" in different cells. The following rows show various characters and symbols such as "$", "GE", "o", "2E", "£z -0", "g 2", "0 2 4 6 8 10 12 14 16 18 20 2 2", "—+—", "Py -0+", ")", "7€", "ao", and "ah", which do not provide any useful information. The last row shows a time scale labeled "Time post-dose (h)" in hours. Overall, it's not clear what this table is for, but it may be related to a medical or pharmaceutical study.*

FDA Label Image

Figure (Tadalafil Figure3)

FDA Label Image

Figure (Tadalafil Figure4)

This is a graph showing the plasma concentration of Tadalafil, a medication used to treat erectile dysfunction. The concentrations are measured in micrograms per liter (ug/L). There are three lines on the graph representing different dosages and administration schedules: a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg Tadalafil following five consecutive days of administration. The x-axis shows time in hours up to 120 hours (or five days) after the medication was taken.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

This text provides information about a clinical trial. It indicates the change from baseline in the IPSS total score in patients who were given tadalafil and placebo. The duration of treatment was 4, 8, and 12 weeks. The significance level for the difference between the two groups was p<0.01.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Tadalafil Tablets 20mg (Tadalafil Label 20mg)

This is a description of Tadalafil Tablets 20mg, which is a generic for Cialis. The tablets come in a film-coated form and should be stored between 20°-25°C. It's prohibited by law to transfer the drug to anyone other than the patient for which it was prescribed. The tablet is oval, yellow, and has the letters A 13 imprinted on it. The manufacturer is Accord Healthcare, Inc., located in Durham, NC. The packaging lot number, expiration date, and batch number are also provided. This text appears to be a medication label, and therefore doesn't provide any other information beyond the medication itself.*

FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.